TY - JOUR
T1 - Current challenges and prevention strategies for chronic total occlusion (CTO) complications
AU - Karacsonyi, Judit
AU - Vemmou, Evangelia
AU - Nikolakopoulos, Ilias
AU - Ungi, Imre
AU - Abi Rafeh, Nidal
AU - ElGuindy, Ahmed
AU - Azzalini, Lorenzo
AU - Burke, M. Nicholas
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
E Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens; owner, Hippocrates LLC; shareholder: MHI Ventures. N Rafeh is a proctor and consultant for BSC, Abbott and shockwave medical. A ElGuindy received consultancy and proctorship fees from Medtronic, Asahi Intecc, Boston Scientific, and Terumo. L Azzalini received consultant fees from Teleflex and Abiomed. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Introduction: Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) can be challenging, but high success rates (85–90%) are currently achieved at experienced centers with approximately 3% risk for a major periprocedural complication. Areas covered: CTO PCI complications can be categorized according to location such as cardiac and non-cardiac (vascular access complications, thromboembolic complications, contrast-related and radiation injury) complications. Cardiac complications are further subdivided into coronary (acute closure, perforation, and equipment loss or entrapment) and non-coronary (hypotension, myocardial infarction, tamponade, arrhythmias). Expert opinion: In this article, we review strategies to prevent and treat CTO PCI complications. Careful monitoring throughout the case enables prevention and early detection of a complication. If a complication occurs, rapid implementation of treatment using an algorithmic approach can minimize its adverse impact.
AB - Introduction: Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) can be challenging, but high success rates (85–90%) are currently achieved at experienced centers with approximately 3% risk for a major periprocedural complication. Areas covered: CTO PCI complications can be categorized according to location such as cardiac and non-cardiac (vascular access complications, thromboembolic complications, contrast-related and radiation injury) complications. Cardiac complications are further subdivided into coronary (acute closure, perforation, and equipment loss or entrapment) and non-coronary (hypotension, myocardial infarction, tamponade, arrhythmias). Expert opinion: In this article, we review strategies to prevent and treat CTO PCI complications. Careful monitoring throughout the case enables prevention and early detection of a complication. If a complication occurs, rapid implementation of treatment using an algorithmic approach can minimize its adverse impact.
KW - Complication
KW - chronic total occlusion
KW - management
KW - percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85104841512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104841512&partnerID=8YFLogxK
U2 - 10.1080/14779072.2021.1905521
DO - 10.1080/14779072.2021.1905521
M3 - Article
C2 - 33730518
AN - SCOPUS:85104841512
SN - 1477-9072
VL - 19
SP - 337
EP - 347
JO - Expert Review of Cardiovascular Therapy
JF - Expert Review of Cardiovascular Therapy
IS - 4
ER -